> Merck & Co will pay Seattle-based Just – Evotec Biologics $15 million upfront to use excess capacity at a biologics facility the company is building in Redmond, Washington. Story
> GBA Group Pharma has doubled the size of its clinical supply facilities in Vienna ahead of Brexit, it says. Release
> DBL Pharmaceuticals says it has a deal to acquire the cream and ointment manufacturing line of GlaxoSmithKline Bangladesh with plans of reintroducing the products that GSK made there before exiting the country. Story
> Helixmith Co. and Genopis say they will launch a contract manufacturing operation to manufacture plasmid DNA for clients. Release
> Medivant Health is building a 33,000-square-foot generic drug manufacturing facility in Chandler, Arizona, to address drug shortages. Story